cbdMD Inc. (YCBD): Price and Financial Metrics


cbdMD Inc. (YCBD): $0.17

-0.02 (-12.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

YCBD Stock Summary

  • YCBD has a higher market value than only 5.51% of US stocks; more precisely, its current market capitalization is $13,020,508.
  • The ratio of debt to operating expenses for CBDMD INC is higher than it is for about just 11.49% of US stocks.
  • Revenue growth over the past 12 months for CBDMD INC comes in at -22.44%, a number that bests merely 8.56% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CBDMD INC are POAI, TIG, MGLD, PATI, and EPM.
  • YCBD's SEC filings can be seen here. And to visit CBDMD INC's official web site, go to www.cbdmd.com.

YCBD Valuation Summary

  • In comparison to the median Healthcare stock, YCBD's EV/EBIT ratio is 104.55% lower, now standing at -0.3.
  • YCBD's EV/EBIT ratio has moved up 26.2 over the prior 64 months.

Below are key valuation metrics over time for YCBD.

Stock Date P/S P/B P/E EV/EBIT
YCBD 2023-03-24 0.4 0.5 -0.2 -0.3
YCBD 2023-03-23 0.4 0.5 -0.2 -0.2
YCBD 2023-03-22 0.4 0.5 -0.2 -0.3
YCBD 2023-03-21 0.4 0.4 -0.2 -0.2
YCBD 2023-03-20 0.3 0.4 -0.2 -0.2
YCBD 2023-03-17 0.3 0.4 -0.2 -0.2

YCBD Growth Metrics

    Its 2 year price growth rate is now at -14.74%.
  • The 4 year price growth rate now stands at -76.73%.
  • The 3 year net income to common stockholders growth rate now stands at 15.56%.
YCBD's revenue has moved down $4,109,822 over the prior 34 months.

The table below shows YCBD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 32.16662 -11.56303 -58.87983
2022-09-30 35.40322 -14.96715 -74.0857
2022-06-30 37.33693 -17.37563 -62.81385
2022-03-31 39.30456 -19.61295 -29.20219
2021-12-31 41.47428 -17.36987 -36.61523
2021-09-30 44.48076 -14.09343 -25.9495

YCBD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • YCBD has a Quality Grade of D, ranking ahead of 8.65% of graded US stocks.
  • YCBD's asset turnover comes in at 0.394 -- ranking 43rd of 50 Consumer Goods stocks.
  • 500 - Internal server error

The table below shows YCBD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.394 0.660 -1.263
2021-03-31 0.398 0.652 -1.673
2020-12-31 0.384 0.654 -0.407
2020-09-30 0.384 0.630 0.483
2020-06-30 0.370 0.647 1.350
2020-03-31 0.354 0.643 0.476

YCBD Stock Price Chart Interactive Chart >

Price chart for YCBD

YCBD Price/Volume Stats

Current price $0.17 52-week high $1.13
Prev. close $0.20 52-week low $0.16
Day low $0.17 Volume 134,298
Day high $0.20 Avg. volume 222,481
50-day MA $0.26 Dividend yield N/A
200-day MA $0.32 Market Cap 11.18M

cbdMD Inc. (YCBD) Company Bio


cbdMD, Inc. is a nationally recognized consumer cannabidiol brand which engages in producing and distributing of CBD products. Its products include CBD tinctures, CBD gummies, CBD topical, CBD bath bombs, and CBD pet products. cbdMD was founded by Caryn Dunayer in March 2015 and is headquartered in Charlotte, NC.


YCBD Latest News Stream


Event/Time News Detail
Loading, please wait...

YCBD Latest Social Stream


Loading social stream, please wait...

View Full YCBD Social Stream

Latest YCBD News From Around the Web

Below are the latest news stories about CBDMD INC that investors may wish to consider to help them evaluate YCBD as an investment opportunity.

cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications

CHARLOTTE, N.C., March 07, 2023--New suite of products allows professionals from all walks of life to add CBD to their regimen without fear of failing a drug test for THC.

Yahoo | March 7, 2023

cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition Summit

Charlotte, North Carolina--(Newsfile Corp. - February 16, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announces its General Counsel, Lance Blundell, and Chief Science Officer, Dr. Sibyl Swift, will be speaking on a panel at the Sports and Active Nutrition Summit, USA - Sponsored by Nutraingredients. The executives will discuss the benefits of CBD in sports nutrition, including the Company's .

Yahoo | February 16, 2023

cbdMD Posts $15 Million in Net Income Improvement over Prior Year Quarter

Company continues to make headway despite challenging consumer environment. Charlotte, North Carolina--(Newsfile Corp. - February 13, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands – including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our first quarter of fiscal 2023 results. For the first quarter of fiscal 2023 Net ...

Yahoo | February 13, 2023

cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC Transaction

Charlotte, North Carolina--(Newsfile Corp. - February 13, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the closing of the return of its $1 million investment following the closing of the ADARA SPAC acquisition on February 10, 2023."We congratulate Adara and Alliance Entertainment, Inc. on all the hard work over the last year to complete the transaction and wish them ...

Yahoo | February 13, 2023

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - February 6, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, February 13, 2023, to discuss the company's December 31, 2022 first quarter of fiscal 2023 financial results and business progress.CONFERENCE CALL DETAILSMonday, February 13, 2023, 4:15 p.

Yahoo | February 6, 2023

Read More 'YCBD' Stories Here

YCBD Price Returns

1-mo -35.09%
3-mo -22.73%
6-mo -26.44%
1-year -82.65%
3-year -80.86%
5-year -95.94%
YTD -25.11%
2022 -78.98%
2021 -63.39%
2020 30.53%
2019 -26.86%
2018 -28.97%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9058 seconds.